Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs.
Nakamura M, Chonabayashi K, Narita M, Matsumura Y, Nishikawa M, Ochi Y, Nannya Y, Hishizawa M, Inoue D, Delwel R, Ogawa S, Takaori-Kondo A, Yoshida Y.
Nakamura M, et al. Among authors: nannya y.
Br J Haematol. 2024 Oct;205(4):1430-1443. doi: 10.1111/bjh.19720. Epub 2024 Aug 26.
Br J Haematol. 2024.
PMID: 39187468